Fig. 1

Cell-based high-throughput screening of FDA-approved drug library identified anidulafungin as an inhibitor of SFTSV infection. A The flowchart of high-throughput screening protocol used to identify inhibitors against SFTSV infection. B Dose-dependent inhibitory effects of six identified compounds revealed via cell-based high-throughput screening of Vero cells